Company Overview
CRISPR THERAPEUTICS AG
CRSPRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
4M
2025 FY
Net Income
-582M
2025 FY
Shares Outstanding
90M
2025 FY
EPS
-6.47USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1674416
Exchange
Nasdaq
Location
CH